Skip to main content
L&C BIO Co., Ltd logo

L&C BIO Co., Ltd — Investor Relations & Filings

Ticker · 290650 ISIN · KR7290650001 KO Manufacturing
Open in API
Filings indexed 379 across all filing types
Latest filing 2018-11-07 Major Shareholding Noti…
Country KR South Korea
Listing KO 290650

About L&C BIO Co., Ltd

http://www.lncbio.co.kr/?locale=en_US

L&C BIO Co., Ltd. is a biotechnology company specializing in regenerative medicine. The company develops, manufactures, and commercializes human tissue-based medical devices and allograft treatment materials. Its core operations include the processing, storage, and distribution of human tissues, with a focus on skin, musculoskeletal, and soft tissues, utilizing patented processing technologies. The company's product portfolio also extends to other medical devices and cosmetics. L&C BIO supports its activities through dedicated research and development centers and manufacturing facilities, including a human tissue plant and a pharmaceutical plant, to advance its pipeline and serve global markets.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed with the Financial Supervisory Service (FSS) in South Korea. It details the shareholding status of Korea Development Bank and its special related party, KDB Capital, in L&C Bio following the company's new listing on the KOSDAQ. This type of filing is a regulatory requirement for entities crossing significant ownership thresholds, which falls under the 'Major Shareholding Notification' category.
2018-11-07 Korean
기타경영사항(특허권취득)(자율공시)
Regulatory Filings Classification · 97% confidence The document is a voluntary disclosure (자율공시) regarding the acquisition of a patent by L&C Bio. It details the patent name, content, holder, and utilization plan. Since it is a specific regulatory announcement regarding corporate activity that does not fit into financial reporting, dividend, or management change categories, it falls under the general regulatory filing category.
2018-11-02 Korean
증권발행실적보고서
Share Issue/Capital Change Classification · 100% confidence The document is a '증권발행실적보고서' (Report on the Results of Securities Issuance) filed with the Financial Supervisory Service (FSS) in South Korea. It details the final results of a capital increase (IPO/share issuance), including subscription amounts, allocation status, and the use of proceeds. This falls under the category of share issuance and capital changes.
2018-10-30 Korean
투자설명서
Regulatory Filings Classification · 99% confidence The document is a '투자설명서' (Investment Prospectus) for L&C Bio, detailing a public offering of 1,000,000 shares. It includes specific sections on offering terms, risk factors, and management confirmation, which are characteristic of a formal securities registration and prospectus filing. In the context of the provided categories, this document serves as a formal offering document for investors, which aligns best with the 'Proxy Solicitation & Information Statement' (PSI) category as it provides detailed information to potential investors for their decision-making process, or alternatively, it functions as a regulatory filing for a capital raise. Given the specific nature of the document as a prospectus for a public offering, it is classified as a PSI.
2018-10-04 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.